THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA

被引：0
|
作者：
Kawanishi, M. [1 ]
Fukuda, T. [1 ]
Inoue, Y. [1 ]
Shimomura, M. [1 ]
Matsubara, H. [1 ]
Wada, T. [1 ]
Tasaka, R. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0211
引用
收藏
页码：1495 / 1495
页数：1
相关论文
共 50 条
  • [1] THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Kawanishi, M.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Tasaka, R.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 288 - 288
  • [2] Expression of UCP2 is associated with the sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Inoue, Yuta
    Fukuda, Takeshi
    Kawanishi, Masaru
    Shimomura, Masahiro
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S9 - S9
  • [3] Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Kawanishi, Masaru
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Wada, Takuma
    Tasaka, Reiko
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2018, 15 (06) : 9923 - 9928
  • [4] THE ASSOCIATION BETWEEN EXPRESSION OF TBX2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Tasaka, R.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Kawanishi, M.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1494 - 1494
  • [5] THE ASSOCIATION BETWEEN EXPRESSION OF TBX2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA
    Tasaka, R.
    Fukuda, T.
    Inoue, Y.
    Shimomura, M.
    Matsubara, H.
    Wada, T.
    Kawanishi, M.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 287 - 287
  • [6] FYN expression is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Noda, Takuya
    Awazu, Yuichiro
    Nanno, Shigenori
    Imai, Kenji
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A207
  • [7] Role of Fyn expression in predicting the sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Sengiku, Tomoki
    Noda, Takuya
    Awazu, Yuichiro
    Wada, Takuma
    Tasaka, Reiko
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [8] PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Matsubara, Hiroaki
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Shimomura, Masahiro
    Inoue, Yuta
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [9] NEUTROPHIL-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY AND PROGNOSIS FOR ADVANCED OVARIAN SEROUS CARCINOMA
    Shimomura, M.
    Fukuda, T.
    Yamauchi, M.
    Kasai, M.
    Hashiguchi, Y.
    Ichimura, T.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 834 - 834
  • [10] ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy
    Saglam, Ozlen
    Xiong, Yin
    Marchion, Douglas C.
    Strosberg, Carolina
    Wenham, Robert M.
    Johnson, Joseph J.
    Saeed-Vafa, Daryoush
    Cubitt, Christopher
    Hakam, Ardeshir
    Magliocco, Anthony M.
    CANCER CONTROL, 2017, 24 (01) : 89 - 95
12345